Mr. Neumann succeeds current CEO Jeffrey Norman, whose tenure is up on Aug. 22. Mr. Norman was appointed CEO in the middle of a “management shake-up” in 2009 after Mark Midei, MD, a cardiologist at the hospital, left amid allegations he had performed numerous unnecessary stent procedures.
His resignation comes shortly after the Maryland Board of Physicians revoked Dr. Midei’s license, writing in an 11-page order that his violations were “repeated and serious.”
Read the report about Charles Neumann.
Related Articles on Maryland Hospital Executive Moves:
Terry Forde Named COO of Adventist HealthCare in Maryland
Baltimore Washington Medical Center in Maryland Names Ronald Andro COO
CEO Martin Doordan to Retire From Maryland’s Anne Arundel Health
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
